Eli Lilly’s Alzheimer’s disease drug is approved by the US FDA
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly’s early-stage Alzheimer’s disease treatment, making it the second treatment to slow the progression of the brain-loss-causing disease to be made available to patients in the United States.
ПОПУЛЯРНЫЕ ПОСТЫ
Putin may discuss Ukraine peace deal with Trump
Ноябрь 22, 2024
Spain’s vice-president Ribera blames floods on climate change
Ноябрь 22, 2024
Storm lashes northwestern US, killing two people
Ноябрь 22, 2024
Iceland volcano erupts for tenth time in three years
Ноябрь 22, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ